Jumping into the vaccine gold mine... or landmine?


In July, the government had agreed for the facilities owned by Pharmaniaga Bhd and Duopharma Biotech Bhd to be used for the fill and finish process of the Covid-19 vaccine.

THE latest buzzword in the market now is vaccine, amid all the fanfare surrounding rubber glove makers who have been enjoying a spectacular run in the coronavirus disease (Covid-19) race.

If there is something that will stop the dominance of rubber gloves in their tracks it will have to be the development of a vaccine.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
vaccine , distribution , Duopharma , NRPA , Pharmaniaga , Covid-19 ,

Next In Business News

Ringgit to remain range-bound at 4.07-4.09 against US dollar next week
AEON Bank integrates MyTentera ID for armed forces personnel
Can co-housing work in Malaysia?
The silent cleaners of the future
Looking beyond the price tag
Big appetites for US snack M&A
Building on opportunity
A gift of growth
Subsidising the EV transition
Inside South Korea’s risky ETF boom

Others Also Read